Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
-15.6%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.01 | -25.9% |
| 2024 | 0.01 | -39.3% |
| 2023 | 0.02 | +33.6% |
| 2022 | 0.01 | - |
| 2021 | 0.00 | +100.0% |
| 2020 | -4.79 | - |
| 2019 | 0.00 | - |